Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Apr;21(4):604–607. doi: 10.1128/aac.21.4.604

In vitro antibacterial activity of norfloxacin (MK-0366).

A King, C Warren, K Shannon, I Phillips
PMCID: PMC181950  PMID: 6211139

Abstract

The in vitro activity of norfloxacin (MK-0366) compared with that of beta-lactam antibiotics and, where appropriate of gentamicin or metronidazole was assessed against recent clinical isolates of common bacteria. The compound was highly active against most enterobacteria (minimal inhibitory concentrations [MICs], 0.008 to 32 micrograms/ml; 90% inhibited by 0.25 micrograms/ml), Haemophilus influenzae (MICs, 0.03 to 0.12 micrograms/ml), and Neisseria gonorrhoeae (MICs, 0.008 to 0.016 micrograms/ml). It was also active against Pseudomonas aeruginosa (MICs, 0.12 to 2 micrograms/ml), most other pseudomonads (MICs, 0.03 to 32 micrograms/ml), and Acinetobacter calcoaceticus (MICs 0.06 to 4 micrograms/ml). Norfloxacin was somewhat less active against staphylococci (MICs, 0.25 to 4 micrograms/ml; 1 microgram/ml required to inhibit 50% of isolates) and streptococci (MICs, 0.5 to 64 micrograms/ml). Members of the Bacteroides fragilis group of anaerobes were relatively resistant to norfloxacin (MICs, 8 to 128 micrograms/ml), as were most other anaerobes.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burman L. G. Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria. J Antimicrob Chemother. 1977 Sep;3(5):509–516. doi: 10.1093/jac/3.5.509. [DOI] [PubMed] [Google Scholar]
  2. Casewell M. W., Talsania H. G. Multiple antibiotic resistance and capsular types of gentamicin-resistant Klebsiella aerogenes. J Antimicrob Chemother. 1981 Mar;7(3):237–244. doi: 10.1093/jac/7.3.237. [DOI] [PubMed] [Google Scholar]
  3. Ito A., Hirai K., Inoue M., Koga H., Suzue S., Irikura T., Mitsuhashi S. In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother. 1980 Feb;17(2):103–108. doi: 10.1128/aac.17.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Khan M. Y., Siddiqui Y., Gruninger R. P. Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1981 Aug;20(2):265–266. doi: 10.1128/aac.20.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES